310 related articles for article (PubMed ID: 38800358)
21. Retrospective analysis of the treatment of melasma lesions exhibiting increased vascularity with the 595-nm pulsed dye laser combined with the 1927-nm fractional low-powered diode laser.
Geddes ER; Stout AB; Friedman PM
Lasers Surg Med; 2017 Jan; 49(1):20-26. PubMed ID: 28134994
[TBL] [Abstract][Full Text] [Related]
22. The role of 755-nm alexandrite picosecond laser in melasma management.
Pulumati A; Jaalouk D; Algarin YA; Nouri K
Arch Dermatol Res; 2023 Dec; 316(1):60. PubMed ID: 38151661
[TBL] [Abstract][Full Text] [Related]
23. Self-applied topical interventions for melasma: a systematic review and meta-analysis of data from randomized, investigator-blinded clinical trials.
Pennitz A; Kinberger M; Avila Valle G; Passeron T; Nast A; Werner RN
Br J Dermatol; 2022 Sep; 187(3):309-317. PubMed ID: 35290681
[TBL] [Abstract][Full Text] [Related]
24. Microneedling-assisted topical tranexamic acid solution versus 4% hydroquinone for treating melasma: A split-face randomized study.
Zaky MS; Obaid ZM; Khalil EA; Elsaie ML
J Cosmet Dermatol; 2021 Dec; 20(12):4011-4016. PubMed ID: 34525492
[TBL] [Abstract][Full Text] [Related]
25. Management of Melasma: Laser and Other Therapies-Review Study.
Jiryis B; Toledano O; Avitan-Hersh E; Khamaysi Z
J Clin Med; 2024 Mar; 13(5):. PubMed ID: 38592701
[TBL] [Abstract][Full Text] [Related]
26. Disorders of hyperpigmentation. Part II. Review of management and treatment options for hyperpigmentation.
Ko D; Wang RF; Ozog D; Lim HW; Mohammad TF
J Am Acad Dermatol; 2023 Feb; 88(2):291-320. PubMed ID: 35158001
[TBL] [Abstract][Full Text] [Related]
27. The efficacy in treatment of facial melasma with thulium 1927-nm fractional laser-assisted topical tranexamic acid delivery: a split-face, double-blind, randomized controlled pilot study.
Wanitphakdeedecha R; Sy-Alvarado F; Patthamalai P; Techapichetvanich T; Eimpunth S; Manuskiatti W
Lasers Med Sci; 2020 Dec; 35(9):2015-2021. PubMed ID: 32506227
[TBL] [Abstract][Full Text] [Related]
28. The efficacy and safety of topical tranexamic acid (liposomal or lotion with microneedling) versus conventional hydroquinone in the treatment of melasma.
Xing X; Chen L; Xu Z; Jin S; Zhang C; Xiang L
J Cosmet Dermatol; 2020 Dec; 19(12):3238-3244. PubMed ID: 33091202
[TBL] [Abstract][Full Text] [Related]
29. Management of hyperpigmentation in darker racial ethnic groups.
Grimes PE
Semin Cutan Med Surg; 2009 Jun; 28(2):77-85. PubMed ID: 19608057
[TBL] [Abstract][Full Text] [Related]
30. Melasma: A critical analysis of clinical trials investigating treatment modalities published in the past 10 years.
Spierings NMK
J Cosmet Dermatol; 2020 Jun; 19(6):1284-1289. PubMed ID: 31603285
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of laser-assisted delivery of tranexamic acid for the treatment of melasma: a systematic review and meta‑analysis.
Feng J; Shen S; Song X; Xiang W
J Cosmet Laser Ther; 2022 Nov; 24(6-8):73-79. PubMed ID: 36403155
[TBL] [Abstract][Full Text] [Related]
32. Topical and Systemic Therapies in Melasma: A Systematic Review.
Sarkar R; Handog EB; Das A; Bansal A; Macarayo MJ; Keshavmurthy V; Narayan V; Jagadeesan S; Pipo E; Ibaviosa GM; Podder I; Bansal S
Indian Dermatol Online J; 2023; 14(6):769-781. PubMed ID: 38099013
[TBL] [Abstract][Full Text] [Related]
33. Postinflammatory and rebound hyperpigmentation as a complication after treatment efficacy of telangiectatic melasma with 585 nanometers Q-switched Nd: YAG laser and 4% hydroquinone cream in skin phototypes III-V.
Lueangarun S; Namboonlue C; Tempark T
J Cosmet Dermatol; 2021 Jun; 20(6):1700-1708. PubMed ID: 33002283
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of the of the efficacy of Fractional Erbium-Doped Yttrium Aluminum Garnet Laser-Assisted Drug Delivery of Kojic Acid in the Treatment of Melasma; A split face, comparative clinical study.
Al-Dhalimi MA; Yasser RH
J Cosmet Laser Ther; 2021 May; 23(3-4):65-71. PubMed ID: 34407729
[TBL] [Abstract][Full Text] [Related]
35. Tranexamic acid microinjections versus tranexamic acid mesoneedling in the treatment of facial melasma: A randomized assessor-blind split-face controlled trial.
Poostiyan N; Alizadeh M; Shahmoradi Z; Fatemi Naeini F
J Cosmet Dermatol; 2023 Apr; 22(4):1238-1244. PubMed ID: 36606390
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of Therapeutic Efficacy and Safety of Tranexamic Acid Local Infiltration in Combination with Topical 4% Hydroquinone Cream Compared to Topical 4% Hydroquinone Cream Alone in Patients with Melasma: A Split-Face Study.
Tehranchinia Z; Saghi B; Rahimi H
Dermatol Res Pract; 2018; 2018():8350317. PubMed ID: 30079087
[TBL] [Abstract][Full Text] [Related]
37. A Split Face Comparative Study of Safety and Efficacy of Microneedling with Tranexamic Acid versus Microneedling with Vitamin C in the Treatment of Melasma.
Menon A; Eram H; Kamath PR; Goel S; Babu AM
Indian Dermatol Online J; 2020; 11(1):41-45. PubMed ID: 32055507
[TBL] [Abstract][Full Text] [Related]
38. Topical Treatments for Melasma: A Systematic Review of Randomized Controlled Trials.
Austin E; Nguyen JK; Jagdeo J
J Drugs Dermatol; 2019 Nov; 18(11):. PubMed ID: 31741361
[TBL] [Abstract][Full Text] [Related]
39. Lasers, lights, and compounds for melasma in aesthetics.
Kamal K; Heitmiller K; Christman M
Clin Dermatol; 2022; 40(3):249-255. PubMed ID: 34838653
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety of a novel picosecond laser using combination of 1 064 and 595 nm on patients with melasma: A prospective, randomized, multicenter, split-face, 2% hydroquinone cream-controlled clinical trial.
Choi YJ; Nam JH; Kim JY; Min JH; Park KY; Ko EJ; Kim BJ; Kim WS
Lasers Surg Med; 2017 Dec; 49(10):899-907. PubMed ID: 28906574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
